IL147774A0 - Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production - Google Patents

Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production

Info

Publication number
IL147774A0
IL147774A0 IL14777400A IL14777400A IL147774A0 IL 147774 A0 IL147774 A0 IL 147774A0 IL 14777400 A IL14777400 A IL 14777400A IL 14777400 A IL14777400 A IL 14777400A IL 147774 A0 IL147774 A0 IL 147774A0
Authority
IL
Israel
Prior art keywords
aminolactams
hydroxyalkanoyl
inhibitors
protein production
related structures
Prior art date
Application number
IL14777400A
Other languages
English (en)
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of IL147774A0 publication Critical patent/IL147774A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14777400A 1999-09-13 2000-09-13 Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production IL147774A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15351199P 1999-09-13 1999-09-13
US22438800P 2000-08-09 2000-08-09
PCT/US2000/024967 WO2001019797A2 (en) 1999-09-13 2000-09-13 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Publications (1)

Publication Number Publication Date
IL147774A0 true IL147774A0 (en) 2002-08-14

Family

ID=26850619

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14777400A IL147774A0 (en) 1999-09-13 2000-09-13 Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production

Country Status (9)

Country Link
EP (1) EP1212306A2 (xx)
JP (1) JP2003509411A (xx)
CN (1) CN1399634A (xx)
AU (1) AU783914B2 (xx)
BR (1) BR0014269A (xx)
CA (1) CA2377221A1 (xx)
IL (1) IL147774A0 (xx)
MX (1) MXPA02001813A (xx)
WO (1) WO2001019797A2 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
US7119085B2 (en) 2000-03-23 2006-10-10 Elan Pharmaceuticals, Inc. Methods to treat alzheimer's disease
MXPA02009729A (es) * 2000-04-03 2003-03-27 Bristol Myers Squibb Pharma Co Lactamas ciclicas como inhibidores de la produccion de la proteina a-beta.
AU2001257006A1 (en) 2000-04-11 2001-10-23 Du Pont Pharmaceuticals Company Substituted lactams as inhibitors of abeta protein production
US6878363B2 (en) 2000-05-17 2005-04-12 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
GB0012671D0 (en) * 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
US7399775B2 (en) * 2001-12-27 2008-07-15 Daiichi Pharmaceutical Co., Ltd. β-amyloid protein production/secretion inhibitor
WO2003094854A2 (en) 2002-05-07 2003-11-20 Elan Pharmaceuticals, Inc. Succinoyl aminopyrazoles and related compounds
TW200502221A (en) * 2002-10-03 2005-01-16 Astrazeneca Ab Novel lactams and uses thereof
JP4220548B2 (ja) 2003-06-05 2009-02-04 エラン ファーマシューティカルズ,インコーポレイテッド アシル化されたアミノ酸・アミジルピラゾール、および関連化合物
JP2010518064A (ja) 2007-02-12 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション Adおよび関連状態の治療のためのピペラジン誘導体
EP2146722A4 (en) 2007-05-10 2011-08-03 Amr Technology Inc ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND THEIR USE FOR BLOCKING THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE
PT2222636E (pt) 2007-12-21 2013-07-16 Ligand Pharm Inc Moduladores seletivos de recetores de andrógeno (sarms) e suas utilizações
EP2291181B9 (en) 2008-04-18 2013-09-11 University College Dublin National University Of Ireland, Dublin Captodiamine for the treatment of depression symptoms
EP3613418A1 (en) 2014-01-17 2020-02-26 Ligand Pharmaceuticals, Inc. Methods and compositions for modulating hormone levels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
KR20000069075A (ko) * 1996-11-22 2000-11-25 진 엠. 듀발 N-(아릴/헤테로아릴/알킬아세틸)아미노산 아미드, 이들을 함유하는 제약 조성물, 및 이들 화합물을 사용하여 베타-아밀로이드 펩티드의 방출 및(또는) 합성의 억제 방법
JP3812952B2 (ja) 1996-12-23 2006-08-23 エラン ファーマシューティカルズ,インコーポレイテッド シクロアルキル、ラクタム、ラクトンおよびその関連化合物およびその医薬組成物、並びに該化合物を用いたβ−アミロイドペプチドの放出および/またはその合成を阻害する方法
IL135564A0 (en) * 1997-12-22 2001-05-20 Elan Pharm Inc POLYCYCLIC α-AMINO-ɛ-CAPROLACTAMS AND RELATED COMPOUNDS
WO1999066934A1 (en) 1998-06-22 1999-12-29 Elan Pharmaceuticals, Inc. CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
WO2000038618A2 (en) 1998-12-24 2000-07-06 Du Pont Pharmaceuticals Company SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Also Published As

Publication number Publication date
CN1399634A (zh) 2003-02-26
WO2001019797A3 (en) 2002-04-11
BR0014269A (pt) 2002-07-02
EP1212306A2 (en) 2002-06-12
AU7479700A (en) 2001-04-17
CA2377221A1 (en) 2001-03-22
AU783914B2 (en) 2005-12-22
JP2003509411A (ja) 2003-03-11
WO2001019797A2 (en) 2001-03-22
MXPA02001813A (es) 2004-03-19

Similar Documents

Publication Publication Date Title
IL147774A0 (en) Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production
HUP0202705A3 (en) Methods and microorganisms or production of panto-compounds
IL149118A0 (en) Inhibitors of neuraminidases
IL142816A0 (en) SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
GB2353810B (en) Cutting elements and methods of manufacture thereof
EP1539692A4 (en) FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB0124299D0 (en) Crystal structure of enzyme and uses thereof
IL135261A (en) Footwear and its method of construction
EP1183030A4 (en) PROCESS FOR THE PREPARATION AND ITS USE OF N-DESMETHYLZOPICLONE
AU3622600A (en) Metalloproteinases and methods of use therefor
HK1044793A1 (en) Mycotoxin-resistant transgenic wheat plant and methods of production and use thereof
PL339486A1 (en) Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same
GB9924334D0 (en) Pharmaceutical products and methods of fabrication therefor
HUP0202519A2 (en) Production of proteins
GB2359003B (en) Method of and line for breadcrumb production
DE60037236D1 (de) Wechselstromgenerator und dessen Herstellungsverfahren
AU3775500A (en) Setting of gemstones
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
AU2001257253A1 (en) Asymmetric synthesis of piperazic acid and derivatives thereof
PL340487A1 (en) Macaroni and method of making same
PL339487A1 (en) Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same
GB9924752D0 (en) Method of construction
ITUD990143A0 (it) Procedimento di produzione di manufatti poliuretanici rivestiti e relativi manufatti
GB9920906D0 (en) Increased production of interferon-a
IL149660A0 (en) Use of enzymes for skin expansion